DEVELOPMENT AND PRODUCTION OF SOLID DOSAGE FORMS

发展治疗学的药物资源分支 美国国家癌症研究所（NCI）癌症治疗部的项目， 寻找一个承包商，为生产提供人员和设施 以及生产用于人体研究的固体口服剂型。 生产任务的数量将每年约六个项目 由10，000至300，000片/胶囊的批量组成。 的 制备的产品将用于NCI申办的临床试验 世界 NCI将使用从该承包商获得的数据 评价产品完整性和支持IND的人员 NCI向美国政府提交的申请。S.食品药品监督管理局 （FDA）。

The Pharmaceutical Resources Branch of the Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute (NCI), is seeking a contractor to provide a staff and facility for the manufacture and production of solid oral dosage forms for investigational use in man. The number of production assignments will approximate six projects annually consisting of batch sizes from 10,000 to 300,000 tablets/capsules. The products prepared will be usedfor NCI-sponsored clinical trials throughout the world. Data obtained from this contractor will be used by NCI personnel to evaluate the integrity of the product, and to support IND applications submitted by the NCI to the U. S. Food and Drug Administration (FDA).